Ortiz, A., Ascencio, A., Rojas, D. P., Sevilla, N. E. A., Zegarra, W. B. O., Montero, E. L. V., Castro, A. A., Alvarez, L. I. M., Valdes, J. R. F., Castillo, J. L., Cortes, J. E., Santellano, B. (2025). Prognosis and survival evaluation in treating high-risk BRAF V600 mutation stage III or IV melanoma with dabrafenib plus trametinib therapy: A meta-analysis of 2,660 patients.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e21501